Method for treating liver diseases of various origins
Abstract
The invention relates to medicine, in particular to gastroenterology, and lies in the field of treatment of liver diseases of various origins. For this purpose, the hepatoprotective agent that is introduced to the patient is embodied as derivatives of bis(2-thio-4,6-dioxo-1,2,3,4,5,6-hexahydropyrimidine-5-yl) arylmethanes. The method provides reduction of the manifestations of cytolysis under the influence of damaging agents and a statistically significant reduction of dysproteinemia, it accelerates restoration of detoxifying processes of the liver, increases induction of endogenic interferon alfa and, consequently, makes the protection of liver cells during hepatitides of various origins more effective.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A compound having formula:
3 . A method of reducing liver damage in a subject in need thereof comprising administering to said subject a therapeutically effective amount of the compound of claim 2 .
4 . The method of claim 3 , wherein the liver damage is caused by a chemical agent.
5 . The method of claim 3 , wherein the liver damage is caused by a bacterial infection.
6 . The method of claim 3 , wherein the liver damage is caused by radiation.
7 . The method of claim 3 , wherein the liver damage is caused by a viral infection.Join the waitlist — get patent alerts
Track US2015158825A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.